Senior insider sale
Chief Financial Officer at ALPHA TAU MEDICAL LTD. — senior position signals high conviction
$290.2K
32.50K shares
What this filing means
LEVY RAPHI plans to sell 32.50K shares of ALPHA TAU MEDICAL LTD. valued at approximately $290.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/4/2026ACC: 0001976408-26-000546
Officer· Chief Financial Officer
Since Mar 2026
32.50K
Shares to sell
$290.2K
Approx. market value
93.71K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Shares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
3/7/2024
71.99KShares issued upon vesting of RSUs
No consideration, shares issued upon vesting of RSUs
3/21/2022
21.72KTotal acquired93.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/7/2024 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 71.99K | — |
3/21/2022 | Shares issued upon vesting of RSUs No consideration, shares issued upon vesting of RSUs | 21.72K | — |
| Total | 93.71K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
32.50K
Market value
$290.2K
6/3/2026
Total
Units
32.50K
Value
$290.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/3/2026 | 32.50K | $290.2K | NASDAQ | Planned |
| Total | 32.50K | $290.2K | ||